Skip to main content
logo
Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
104.79
-4.90 (-4.47%)
Aug 20, 2026, 4:00 PM EDT - Market closed

Oruka Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
268.4746.9461.58
Short-Term Investments
605.09290.11314.07
Cash & Short-Term Investments
873.56337.04375.65
Cash Growth
166.00%-10.28%-
Prepaid Expenses
116.811.22
Total Current Assets
884.56343.86376.87
Property, Plant & Equipment
2.692.121.04
Long-Term Investments
252.02142.5418.07
Other Long-Term Assets
0.130.10.04
Total Assets
1,139488.62396.02

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
7.954.163.46
Accrued Expenses
14.3510.69.37
Current Portion of Leases
0.670.620.21
Total Current Liabilities
22.9715.3713.04
Long-Term Leases
1.881.310.76
Total Liabilities
24.8516.6913.8

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
0.060.050.04
Additional Paid-In Capital
1,375657.56463.02
Retained Earnings
-262.18-189.16-83.72
Comprehensive Income & Other
-1.70.55-0.04
Total Common Equity
1,112469379.29
Shareholders' Equity
1,115471.93382.22
Total Liabilities & Equity
1,139488.62396.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
2.551.930.97
Net Cash (Debt)
1,123477.65392.75
Net Cash Growth
221.66%21.62%-
Net Cash Per Share
20.7210.4723.39
Filing Date Shares Outstanding
66.2149.5437.44
Total Common Shares Outstanding
61.0748.7237.44
Working Capital
861.59328.48363.83
Book Value Per Share
18.209.6310.13
Tangible Book Value
1,112469379.29
Tangible Book Value Per Share
18.209.6310.13
SEC Filings: 10-K · 10-Q